StonvexLoading…
StonvexStonvexStonvexCore line items from DY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-01-25 | Annual 2024 2024-01-27 | Annual 2023 2023-10-28 |
|---|---|---|---|---|
Revenue | $5.55B | $4.70B | $4.18B | $1.14B |
Operating Income | $367.88M | $307.79M | $292.00M | Not available |
Net Income | $281.19M | $233.41M | $218.92M | $83.74M |
EPS (Diluted) | $9.56 | $7.92 | $7.37 | $2.82 |
Total Assets | $5.98B | $2.95B | $2.52B | Not available |
Total Liabilities | $4.12B | $1.71B | $1.46B | Not available |
Cash & Equivalents | $709.16M | $92.67M | $101.09M | Not available |
Free Cash Flow OCF − CapEx | $401.71M | $98.64M | $40.48M | Not available |
Shares Outstanding | 29.97M | 28.98M | 29.09M | Not available |